These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 25550693)

  • 1. The CD28-B7 Family in Anti-Tumor Immunity: Emerging Concepts in Cancer Immunotherapy.
    Leung J; Suh WK
    Immune Netw; 2014 Dec; 14(6):265-76. PubMed ID: 25550693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphocyte coreceptors].
    Olive D
    Med Sci (Paris); 2006 Dec; 22(12):1069-74. PubMed ID: 17156728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy.
    Khan M; Arooj S; Wang H
    Front Immunol; 2021; 12():651634. PubMed ID: 34531847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies.
    Pulanco MC; Madsen AT; Tanwar A; Corrigan DT; Zang X
    Cell Mol Immunol; 2023 Jul; 20(7):694-713. PubMed ID: 37069229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7-H3 role in the immune landscape of cancer.
    Castellanos JR; Purvis IJ; Labak CM; Guda MR; Tsung AJ; Velpula KK; Asuthkar S
    Am J Clin Exp Immunol; 2017; 6(4):66-75. PubMed ID: 28695059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy.
    Picarda E; Ohaegbulam KC; Zang X
    Clin Cancer Res; 2016 Jul; 22(14):3425-3431. PubMed ID: 27208063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive molecular profiling of the B7 family of immune-regulatory ligands in breast cancer.
    Xu Z; Shen J; Wang MH; Yi T; Yu Y; Zhu Y; Chen B; Chen J; Li L; Li M; Zuo J; Jiang H; Zhou D; Luan J; Xiao Z
    Oncoimmunology; 2016 Aug; 5(8):e1207841. PubMed ID: 27622076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of Immune Checkpoints: An Overview on the CD28-B7 Family.
    Liu W; Zang X
    Adv Exp Med Biol; 2019; 1172():63-78. PubMed ID: 31628651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The B7 family revisited.
    Greenwald RJ; Freeman GJ; Sharpe AH
    Annu Rev Immunol; 2005; 23():515-48. PubMed ID: 15771580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell coinhibition and immunotherapy in human breast cancer.
    Janakiram M; Abadi YM; Sparano JA; Zang X
    Discov Med; 2012 Oct; 14(77):229-36. PubMed ID: 23114578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood gene expression of B7 and CD28 family members associated with tumor progression and microscopic lymphovascular invasion in colon cancer patients.
    Lee H; Kim JH; Yang SY; Kong J; Oh M; Jeong DH; Chung JI; Bae KB; Shin JY; Hong KH; Choi I
    J Cancer Res Clin Oncol; 2010 Sep; 136(9):1445-52. PubMed ID: 20140740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity.
    Denfeld RW; Dietrich A; Wuttig C; Tanczos E; Weiss JM; Vanscheidt W; Schöpf E; Simon JC
    Int J Cancer; 1995 Jul; 62(3):259-65. PubMed ID: 7543078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules.
    D'Arrigo P; Tufano M; Rea A; Vigorito V; Novizio N; Russo S; Romano MF; Romano S
    Curr Med Chem; 2020; 27(15):2402-2448. PubMed ID: 30398102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics.
    Barach YS; Lee JS; Zang X
    Trends Mol Med; 2011 Jan; 17(1):47-55. PubMed ID: 20971039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.
    MacGregor HL; Sayad A; Elia A; Wang BX; Katz SR; Shaw PA; Clarke BA; Crome SQ; Robert-Tissot C; Bernardini MQ; Nguyen LT; Ohashi PS
    J Immunother Cancer; 2019 Dec; 7(1):357. PubMed ID: 31892360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7 family protein glycosylation: Promising novel targets in tumor treatment.
    Xiao L; Guan X; Xiang M; Wang Q; Long Q; Yue C; Chen L; Liu J; Liao C
    Front Immunol; 2022; 13():1088560. PubMed ID: 36561746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revealing the atomistic details behind the binding of B7-1 to CD28 and CTLA-4: A comprehensive protein-protein modelling study.
    Ganesan A; Moon TC; Barakat KH
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2764-2778. PubMed ID: 30251665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy.
    Zhao B; Li H; Xia Y; Wang Y; Wang Y; Shi Y; Xing H; Qu T; Wang Y; Ma W
    J Hematol Oncol; 2022 Oct; 15(1):153. PubMed ID: 36284349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.
    Yonesaka K; Haratani K; Takamura S; Sakai H; Kato R; Takegawa N; Takahama T; Tanaka K; Hayashi H; Takeda M; Kato S; Maenishi O; Sakai K; Chiba Y; Okabe T; Kudo K; Hasegawa Y; Kaneda H; Yamato M; Hirotani K; Miyazawa M; Nishio K; Nakagawa K
    Clin Cancer Res; 2018 Jun; 24(11):2653-2664. PubMed ID: 29530936
    [No Abstract]   [Full Text] [Related]  

  • 20. The CD28-B7 Family of Co-signaling Molecules.
    Nagai S; Azuma M
    Adv Exp Med Biol; 2019; 1189():25-51. PubMed ID: 31758530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.